Company intelligence / Profile preview

RizLab Health

Princeton, New Jersey, United Statesrizlabhealth.com ↗

Ownership: Private
Development stage: Preclinical

Overview

RizLab Health has developed the CytoTracker, an ultra-portable, wireless point-of-care analyzer that quantifies white blood cells and their subtypes from a single drop of blood within minutes. In a 200-person clinical study, CytoTracker demonstrated higher specificity than current testing methods in differentiating bacterial from viral infections. The device is currently approved only for research use.

Therapeutic areas: Infectious Diseases
Modalities: Device (point-of-care analyzer)Artificial intelligence-powered diagnostics
Industry: Pathology

Beyond the preview

Go deeper on RizLab Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RizLab Health.

Explore the full profile